135 related articles for article (PubMed ID: 26022162)
1. Prognostic significance of Nemo-like kinase expression in patients with hepatocellular carcinoma.
Chen HW; Qiao HY; Li HC; Li ZF; Zhang HJ; Pei L; Liu HW; Jin L; Wang D; Li JL
Tumour Biol; 2015 Nov; 36(11):8447-53. PubMed ID: 26022162
[TBL] [Abstract][Full Text] [Related]
2. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.
Huang Y; Yang Y; He Y; Li J
Tumour Biol; 2015 Dec; 36(12):9147-52. PubMed ID: 26427665
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer.
Li M; Zhang S; Wang Z; Zhang B; Wu X; Weng H; Ding Q; Tan Z; Zhang N; Mu J; Yang J; Shu Y; Bao R; Ding Q; Wu W; Cao Y; Liu Y
Tumour Biol; 2013 Dec; 34(6):3995-4000. PubMed ID: 23857283
[TBL] [Abstract][Full Text] [Related]
7. Expression of Nemo-like kinase was increased and negatively correlated with the expression of TCF4 in lung cancers.
Zhang XW; Chen SY; Xue DW; Xu HH; Yang LH; Xu HT; Wang EH
Int J Clin Exp Pathol; 2015; 8(11):15086-92. PubMed ID: 26823848
[TBL] [Abstract][Full Text] [Related]
8. Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis.
Lv M; Li Y; Tian X; Dai S; Sun J; Jin G; Jiang S
Drug Des Devel Ther; 2016; 10():3737-3746. PubMed ID: 27895463
[TBL] [Abstract][Full Text] [Related]
9. Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.
Wang J; Yang ZH; Chen H; Li HH; Chen LY; Zhu Z; Zou Y; Ding CC; Yang J; He ZW
BMC Cancer; 2016 Mar; 16():257. PubMed ID: 27036119
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma.
Chen H; Miao J; Li H; Wang C; Li J; Zhu Y; Wang J; Wu X; Qiao H
J Surg Res; 2014 Jun; 189(1):81-8. PubMed ID: 24576777
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of nemo-like kinase in nasopharyngeal carcinoma.
Chen S; Ma Z; Chen X; Zhang J
Mol Med Rep; 2014 Jul; 10(1):131-6. PubMed ID: 24789020
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma.
Sohn BH; Shim JJ; Kim SB; Jang KY; Kim SM; Kim JH; Hwang JE; Jang HJ; Lee HS; Kim SC; Jeong W; Kim SS; Park ES; Heo J; Kim YJ; Kim DG; Leem SH; Kaseb A; Hassan MM; Cha M; Chu IS; Johnson RL; Park YY; Lee JS
Clin Cancer Res; 2016 Mar; 22(5):1256-64. PubMed ID: 26459179
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biological significance of nemo-like kinase expression in glioma.
Cui G; Li Z; Shao B; Zhao L; Zhou Y; Lu T; Wang J; Shi X; Wang J; Zuo G; Zhu W; Shen A
J Clin Neurosci; 2011 Feb; 18(2):271-5. PubMed ID: 21177110
[TBL] [Abstract][Full Text] [Related]
14. High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma.
Huang W; Cui X; Chen Y; Shao M; Shao X; Shen Y; Liu Q; Wu M; Liu J; Ni W; Lu C; Wan C
Pathol Res Pract; 2016 Mar; 212(3):171-8. PubMed ID: 26706601
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis.
Lei L; Wang Y; Zheng YW; Fei LR; Shen HY; Li ZH; Huang WJ; Yu JH; Xu HT
Curr Cancer Drug Targets; 2019; 19(8):674-680. PubMed ID: 30451112
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of polycomb protein Ring1 contributes to poor prognosis and accelerated proliferation in human hepatocellular carcinoma.
Xiong Y; Hu B; Wei L; Jiang D; Zhu M
Tumour Biol; 2015 Dec; 36(12):9579-88. PubMed ID: 26141041
[TBL] [Abstract][Full Text] [Related]
17. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B
Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347
[TBL] [Abstract][Full Text] [Related]
18. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
19. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
[TBL] [Abstract][Full Text] [Related]
20. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
